[1]
2019. Enhancing immune effects of a DNA vaccine against kidney cancer using CD40L as an adjuvant. Brazilian Journal of Pharmaceutical Sciences. 55, (Dec. 2019), e18173. DOI:https://doi.org/10.1590/s2175-97902019000218173.